文献速递头颈部肿瘤放疗放疗物理与技术

高剂量电离辐射诱导铁死亡增敏鼻咽癌放疗

High-dose ionizing radiation-induced ferroptosis leads to radiotherapy sensitization of nasopharyngeal carcinoma.
PubMed 文献 · Radiother Oncol · 2025-10-05

该研究回顾性分析73例鼻咽癌患者放疗前后铁代谢标志物变化,并在5-8F细胞中探讨不同剂量电离辐射对铁死亡相关基因与生化指标的影响。结果显示高剂量辐射可诱导鼻咽癌细胞铁死亡,且耐药细胞中铁死亡驱动基因表达较低,提示铁死亡靶点可能克服放疗抵抗。

要点

  • 鼻咽癌放疗后血清铁和转铁蛋白饱和度显著升高,血红蛋白和UIBC显著降低。
  • 5-8F细胞在2-18 Gy辐射后10 Gy时活力最低,高剂量辐射上调促铁死亡基因并下调GPX4。
  • 高剂量辐射使鼻咽癌细胞阻滞于G2/M期,放射抵抗细胞中铁死亡驱动基因表达较低。

核心结论

  • 高剂量电离辐射可诱导鼻咽癌细胞发生铁死亡,提示基于铁死亡的靶点开发可能用于克服临床鼻咽癌放疗抵抗。

研究设计与样本

  • 回顾性分析73例鼻咽癌患者放疗前后铁代谢标志物变化,并在5-8F细胞中采用CCK-8、RT-qPCR、Western blot、流式细胞术等检测不同剂量电离辐射对铁死亡相关指标的影响。

主要发现

  • 放疗后血清铁和转铁蛋白饱和度较放疗前显著升高,血红蛋白和UIBC显著降低。
  • 5-8F细胞在2-18 Gy辐射后10 Gy时活力最低。
  • 辐射后鼻咽癌细胞中ACSL4、PTGS2、IREB2的mRNA表达总体上调,GPX4蛋白水平下调。
  • 随辐射剂量增加,LDH、ROS、MDA含量上调,ATP和GSH水平下调。
  • 高剂量辐射可将鼻咽癌细胞阻滞于G2/M期,放射抵抗细胞系中三个铁死亡驱动基因表达水平较低。

临床怎么用

  • 鼻咽癌放疗后应关注铁代谢标志物变化,高剂量辐射诱导铁死亡的特征可能为增敏策略提供靶点。

局限性

  • 原文未报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Radiotherapy (RT) is the most commonly-used treatment for nasopharyngeal carcinoma (NPC). Ferroptosis is a type of regulated cell death that is associated with cancer development. This study aims to investigate the relationship between RT and iron metabolism in NPC patients, as well as the effects of different doses of ionizing radiation (IR) on NPC cells and the role played by ferroptosis METHODS AND MATERIALS: A retrospective analysis was conducted on changes in iron metabolism markers-serum iron, hemoglobin, TIBC, UIBC, and transferrin saturation-before and after radiotherapy in 73 participants. CCK-8 assay was used to assess the effects of varying radiation doses on the viability of 5-8F cells, determining the radiation dose applied in this study. Real-time quantitative PCR (RT-qPCR) was performed to examine how different radiation doses affect the expression of ferroptosis-related genes (FRGs), including ACSL4, ATP5G3, PTGS2, and IREB2. Western blot analysis was employed to measure the protein expression levels of GPX4 under varying radiation doses. The contents of lactate dehydrogenase (LDH), reactive oxygen species (ROS), malonaldehyde (MDA), [Fe2+], adenosine triphosphate (ATP), and glutathione (GSH) were assessed to evaluate the induction of ferroptosis. In addition, flow cytometry was used to analyze cell cycle distribution in NPC cells following various doses of IR. FRGs expression was assessed in NPC cell lines with varying radiosensitivity RESULTS: Compared to pre-radiotherapy levels, serum iron and transferrin saturation significantly increased after treatment, while hemoglobin and UIBC showed marked reductions. The CCK8 results indicated that after exposure to 2-18 Gy of radiation, the viability of 5-8F cells was lowest at a dose of 10 Gy. In irradiated NPC cells, mRNA expression of pro-ferroptosis factors such as ACSL4, PTGS2, and IREB2 was generally upregulated, whereas protein levels of the anti-ferroptosis factor GPX4 were downregulated. As the IR dose increased, the contents of LDH, ROS, and MDA were upregulated, while ATP and GSH levels were downregulated. In addition, high-dose IR exposure can block NPC cells in the G2/M phase. Moreover, we found that the expression levels of three ferroptosis driver genes were lower in radioresistant NPC cell line CONCLUSIONS: High dose IR can induce ferroptosis in NPC cells, highlighting the potential for developing novel ferroptosis-based targets and overcoming radioresistance in clinical NPC treatments.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Jin X, Zeng X, Yang D, et al. High-dose ionizing radiation-induced ferroptosis leads to radiotherapy sensitization of nasopharyngeal carcinoma. Radiother Oncol. 2025. PMID: 41057083. doi:10.1016/j.radonc.2025.111166

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。